A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C

Hepatology

Volumn 33, Issue 1, 2001, Pages 218-223

  Orito, Etsuro ^a   Mizokami, Masashi ^a   Sakugawa, Hiroshi ^b   Michitaka, Kojiro ^c   Ishikawa, Kazuyoshi ^d   Ichida, Takafumi ^e   Okanoue, Takeshi ^f   Hige, Shyuhei ^g,h   Shinzawa, Haruhide ⁱ   Watanabe, Hisatsuyo ⁱ   Tanaka, Eiji ^j   Kiyosawa, Kendo ^j   Hino, Keisuke ^k   Okita, Kiwamu ^k   Onji, Morikazu ^c   Horiike, Norio ^c   Fukuizumi, Kunitaka ^l   Sata, Michio ^l   Mukaide, Motokazu ^m   Ohno, Tomoyoshi ^a   Kondo, Yutaka ^a   Kato, Hideaki ^a   Sugauchi, Fuminaka ^a   Suzuki, Seiji ^a   Kimura, Yoshihide ^a   more..

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c EHIME UNIVERSITY   (Japan)

^d IWATE PREFECTURAL UNIVERSITY   (Japan)

^e NIIGATA UNIVERSITY   (Japan)

^f KYOTO PREFECTURAL UNIVERSITY   (Japan)

^g ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h HOKKAIDO UNIVERSITY   (Japan)

ⁱ YAMAGATA UNIVERSITY   (Japan)

^j SHINSHU UNIVERSITY   (Japan)

^k YAMAGUCHI UNIVERSITY   (Japan)

^l KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^m SRL INC   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; NUCLEOTIDE; VIRUS DNA;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHRONIC HEPATITIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEX DIFFERENCE; VIRUS MUTANT;

EID: 0035196637     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.20532     Document Type: Article

References (40)

1. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants
2. Natural history and control of perinatally acquired hepatitis B virus infection
3. Hepatitis B virus unable to secrete e antigen
4. Fulminant hepatitis B: Induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen
5. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis
6. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis
7. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection
8. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen
9. Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis
10. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen
11. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication
12. Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated
13. The precore/core promoter mutant (T1762A1764) of hepatitis B virus: Clinical significance and an easy method for detection
14. Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes
15. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes
16. A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness
17. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene
18. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus - Large-scale analysis using a new genotyping method
19. Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns
20. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product
21. Hepatitis B virus infection: Precore mutants and its relation to viral genotypes and core mutations
22. Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation
23. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B
24. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion
25. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers
26. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B
27. Association of mutations in the core promoter and precore region of hepatitis virus with fulminant and severe acute hepatitis in Japan
28. The molecular basis of hepatitis B e antigen (HBeAg)-negative infections
29. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C
30. Current state of interferon therapy for chronic hepatitis C
31. Hepatitis C virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics
32. Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C
33. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B
34. Genotypic differences in the hepatitis B virus core promoter and precore sequences during seroconversion from HBeAg to anti-HBe
35. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: Possible contribution of a single nucleotide in the precore region
36. Variability in hepatitis B virus DNA: Phylogenetic, epidemiological and clinical implications
37. High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers
38. A revised secondary structure model for the 3′-end of hepatitis B virus pregenomic RNA
39. Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression
40. Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation